Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06837571 · ClinicalTrials.gov registry record
Methadone Dose Monitoring With a Remote Medication Monitor
A clinical trial, sponsored by Cari Health.
- Not yet
- Registry status
- 30
- Enrollment target
NCT06837571 is a clinical trial that has not yet begun recruiting, run by Cari Health. The registered enrollment target is 30 participants.
The verdict
NCT06837571 has not yet begun recruiting, sponsored by Cari Health.
- NOT YET RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication adherence monitor and would allow for the physician, counselor, patient, or family member to remotely verify that a physician-prescribed dose has been taken.
Interventions
- DIAGNOSTIC_TEST Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo
- DRUG Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo
- DEVICE ISF Extraction Device 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-04-26 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06837571
The ClinicalTrials.gov registry entry for NCT06837571 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cari Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo is the first listed.
NCT06837571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06837571 about?
NCT06837571 is a clinical study titled "Methadone Dose Monitoring With a Remote Medication Monitor". Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication ...
What is the current status of trial NCT06837571?
This trial is currently not yet recruiting. The enrollment target is 30 participants. The study started on 2025-04-26. Estimated completion is 2025-06.
What interventions are being tested in trial NCT06837571?
The interventions under investigation include: Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo (DIAGNOSTIC_TEST), Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo (DRUG), ISF Extraction Device 2 (DEVICE).
Who is sponsoring clinical trial NCT06837571?
This trial is sponsored by Cari Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.